8-K: Centrus Reports Strong 2025 Results, Secures $900M HALEU Award
Annual Results
Centrus Energy Corp. announced robust full-year 2025 financial results, including increased revenue and net income, alongside a significant $900 million HALEU production award from the U.S. Department of Energy.
Summary
- Full year 2025 revenue reached $448.7 million, an increase from $442.0 million in 2024.
- Gross profit for the full year 2025 was $117.5 million, up from $111.5 million in 2024.
- Net income for the full year 2025 was $77.8 million, compared to $73.2 million in 2024.
- The company's unrestricted cash balance significantly increased to $2.0 billion.
- Centrus successfully enriched over 1 metric ton of High-Assay Low-Enriched Uranium (HALEU) UF6.
- The U.S. Department of Energy (DOE) selected Centrus for a $900.0 million HALEU production award, subject to negotiation.
- The National Nuclear Security Administration (NNSA) notified Centrus of its intent to sole source certain uranium enrichment activities.
- Centrus launched domestic commercial centrifuge manufacturing to support its substantial $2.3 billion commercial low enriched uranium (LEU) backlog.
- Total backlog as of December 31, 2025, stands at $3.8 billion, extending to 2040.
- The LEU segment backlog is approximately $2.9 billion, including $2.3 billion in contingent LEU sales contracts.
- The Technical Solutions segment backlog is approximately $0.9 billion.
- For 2026, Centrus expects total revenue to be in the range of $425 million to $475 million.
- Total capital deployment for 2026 is projected to be between $350 million and $500 million, driven by industrial build-out investments.
Sentiment
Score: 8
Explanation: StockSavvy.ai views this as a very positive report, driven by strong financial growth, significant government contract awards for HALEU production, and strategic advancements in domestic enrichment capacity, despite some minor segment-level declines and contract delays.
Positives
- Full year 2025 revenue increased to $448.7 million from $442.0 million in 2024.
- Full year 2025 gross profit increased to $117.5 million from $111.5 million in 2024.
- Full year 2025 net income increased to $77.8 million from $73.2 million in 2024.
- Unrestricted cash balance significantly increased to $2.0 billion.
- Successful enrichment of over 1 metric ton of HALEU UF6.
- Selection by the DOE for a $900.0 million HALEU production award, subject to negotiation.
- Notification from NNSA of its intent to sole source certain uranium enrichment activities from Centrus.
- Launch of domestic commercial centrifuge manufacturing, marking a strategic transformation.
- Substantial total backlog of $3.8 billion as of December 31, 2025, extending to 2040, including $2.3 billion in contingent LEU sales.
- LEU segment gross profit increased by 19% to $111.5 million due to increased SWU volume and improved margin.
Negatives
- LEU segment revenue decreased by $3.7 million (1%) to $346.2 million in 2025 compared to $349.9 million in 2024.
- Uranium revenue decreased by $55.6 million (54%) to $47.5 million in 2025 compared to $103.1 million in 2024.
- Technical Solutions segment gross profit decreased by $11.6 million (66%) to $6.0 million in 2025, primarily due to increased costs incurred under the HALEU Operation Contract.
- The lower end of the 2026 revenue guidance ($425 million) is below the actual 2025 revenue ($448.7 million).
Risks
- The war in Ukraine and other geopolitical conflicts, including resulting bans, laws, tariffs, sanctions, or other government measures, and actions by third parties, could directly or indirectly impact the ability to obtain, deliver, transport, sell, or collect payment for LEU or its components.
- Reliance on third-party suppliers to provide essential products and services.
- Restrictions on imports and exports, including those imposed under the RSA and related international trade legislation.
- Risks associated with government contracts, including government shutdowns, changes to U.S. government appropriated funding levels for HALEU, and the government's inability to satisfy its obligations.
- Uncertainty regarding the receipt of additional task orders under the HALEU Production Contract, LEU Production Contract, and HALEU Deconversion Contract, and their nature, timing, and amount if awarded.
- Ability to obtain new contracts or funding to continue operations.
- Uncertainty regarding when government demand for HALEU or LEU for government or commercial uses will materialize and at what level.
- The impact and potential extended duration of a supply/demand imbalance in the market for LEU.
- Significant competition from major LEU producers, including foreign competitors who may be less cost-sensitive.
- Limitations on the ability to compete in foreign markets.
- Pricing trends and demand in the uranium and enrichment markets, especially in light of potential limited supply and dependence on others for deliveries of LEU.
- Ability to successfully implement planned expansion projects in Piketon, Ohio, and Oak Ridge, Tennessee.
- Natural and other disasters; pandemics and other health crises.
- Revenue is largely dependent on largest customers and sales backlog.
- Long-term liabilities, including postretirement health and life benefit obligations, 0% Convertible Notes, and 2.25% Convertible Notes.
- Failures or security, including cybersecurity, breaches of information technology systems.
- The impact of, or changes to, government regulation and policies or interpretation of laws or regulations, including by the SEC, DOE, DOC, and NRC.
Future Outlook
Centrus expects 2026 total revenue to be in the range of $425 million to $475 million and total capital deployment to be between $350 million and $500 million, driven by increased investment in centrifuge manufacturing. Operationally, the company plans to finalize contracts with critical partners, hire at least 100 net new employees for Oak Ridge and 50 for Piketon, and release a Certified for Construction package. The company targets 12 metric tons of HALEU production per year sometime after 2030, with at least some HALEU production by the end of the decade.
Management Comments
- "2025 was a milestone year for Centrus marked by continuous improvements to both our existing LEU segment as well as our planned future enrichment business, punctuated by our fourth quarter announcement officially launching our centrifuge build out and the governments selection of Centrus for a $900 million HALEU enrichment award." Amir Vexler, President and CEO.
- "With a growing contingent LEU sales backlog of $2.3 billion, a HALEU mandate from the government, and a potential sole-source award from the NNSA, we are uniquely positioned to meet the commercial and national security market needs." Amir Vexler, President and CEO.
- "Importantly, our substantial LEU backlog and proposed 12 metric tons of HALEU production should allow us to meet our milestone of reaching nth-of-a-kind cost." Amir Vexler, President and CEO.
- "The LEU pricing curves sharp rise continues to demonstrate that there is a clear need for additional enrichment capacity for growing electrification demands." Amir Vexler, President and CEO.
- "Centrus is excited to provide a uniquely American solution to the current critical fuel needs from the existing nuclear reactor fleet and national security establishment, as well as the future needs for the advanced reactor HALEU market that will power tomorrows data centers and AI technologies." Amir Vexler, President and CEO.
Industry Context
StockSavvy.ai notes that Centrus's strong performance and strategic awards align with a growing global demand for nuclear energy, particularly for advanced reactors requiring HALEU. The sharp rise in LEU pricing curves indicates a clear need for additional enrichment capacity, positioning Centrus as a key domestic supplier amidst geopolitical shifts impacting Russian LEU supply and increasing electrification demands driven by data centers and AI technologies.
Comparison to Industry Standards
- The filing does not provide specific comparable companies, projects, or results to global benchmarks for direct assessment against industry standards.
Stakeholder Impact
- Shareholders: Positive impact due to increased revenue, net income, cash balance, significant government contracts, and strategic expansion, potentially leading to increased share value.
- Employees: Positive impact with plans for at least 150 net new hires across Oak Ridge and Piketon facilities.
- Customers: Enhanced long-term supply security for LEU and future HALEU, especially for U.S. and international customers with existing contracts.
- Government (DOE, NNSA): Centrus is positioned as a critical partner for national security and clean energy initiatives, providing domestic uranium enrichment capabilities.
- Suppliers: Potential for increased business due to the company's industrial build-out and centrifuge manufacturing.
Next Steps
- Negotiate the $900.0 million HALEU production award with the DOE.
- Begin construction activities for the 150,000 square foot training, operations & maintenance facility in Piketon, Ohio, in early 2026.
- Finalize contracts with all partners identified as critical to its industrial build out in 2026.
- Hire at least 100 net new employees for the Oak Ridge, Tennessee, facility in 2026.
- Hire at least 50 net new employees for the Piketon, Ohio, facility in 2026.
- Release a Certified for Construction package in 2026.
- Target 12 metric tons of HALEU production per year sometime after 2030.
- Achieve at least some HALEU production by the end of the decade.
Key Dates
| Date | Description |
|---|---|
| December 31, 2024 | Prior year financial results for comparison. |
| September 2025 | Centrus announced plans for a major expansion of its uranium capacity in Piketon, Ohio, including large-scale production of both LEU and HALEU. |
| December 2025 | Initiated design work on a 150,000 square foot training, operations & maintenance facility in Piketon, Ohio. Began domestic centrifuge manufacturing to support commercial LEU enrichment activities. |
| December 31, 2025 | End of the fiscal year for which financial results are reported. Total backlog was $3.8 billion. |
| January 5, 2026 | DOE announced that American Centrifuge Operating, LLC, a Centrus subsidiary, was selected for a $900.0 million task order award, subject to negotiations, to expand HALEU production. |
| January 31, 2026 | Extended completion date for Phase 2 of the HALEU Operation Contract. |
| February 10, 2026 | Date of the press release announcing financial results and the 8-K filing. |
| Early 2026 | Construction activities for the Piketon, Ohio, training, operations & maintenance facility are set to begin. |
| 2026 | Full year financial and operational guidance provided, including plans to finalize contracts, hire new employees, and release a Certified for Construction package. |
| End of the decade | Target for achieving at least some HALEU production. |
| After 2030 | Target for 12 metric tons of HALEU production per year. |
| 2040 | The company's total backlog extends to this year. |
Recommendation
strong buyThe company reported strong financial results with increased revenue, gross profit, and net income, alongside a substantial increase in cash. The securing of a $900 million HALEU production award from the DOE and the NNSA's intent to sole source certain activities are significant catalysts, de-risking future growth and establishing Centrus as a critical player in the domestic nuclear fuel supply chain. The launch of domestic centrifuge manufacturing and a growing backlog further solidify its market position and future prospects in a high-demand industry.
Keywords
Uranium enrichment, HALEU, LEU, nuclear fuel, Centrus Energy, DOE award, NNSA, Piketon Ohio, centrifuge manufacturing, nuclear power, energy security, financial results, 8-K, LEU backlog
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.